1) Visfatin
内脂素
1.
Relationship between Visfatin and Type 2 Diabetes;
内脂素与2型糖尿病的关系
2.
Effects of fenofibrate on adiponectin and visfatin plasma concentrations in rats with lipid-induced insulin resistance;
非诺贝特对高脂饮食诱导胰岛素抵抗大鼠血浆脂联素和内脂素的影响
3.
Relationship Between the Expression of Visfatin in Visceral Fat Tissue and Insulin Resistance Induced by High Fat Diet in Rats;
高脂饮食诱导的胰岛素抵抗大鼠内脂素的表达水平
2) Visfatin
Visfatin
1.
Visfatin and Metabolic Syndrome;
Visfatin与代谢综合征
2.
Progress in Visfatin/PBEF/Nampt;
Visfatin/PBEF/Nampt的研究进展
3.
Bioinformatics analysis of the transcriptional regulation of Visfatin;
Visfatin转录调控的生物信息学分析
3) Visfatin
内肥素
1.
Study on Relationship between Plasma Visfatin of Type 2 Diabetes and Triglycerid;
2型糖尿病血浆内肥素与甘油三酯相关性研究
2.
Study on Relationship between WHtR and Plasma Visfatin of Newly Diagnosed Type 2 Diabetes;
2型糖尿病血浆内肥素与WHtR相关性研究
3.
Change of Plasma Visfatin Level in Patients with Type 2 Diabetes;
2型糖尿病患者血浆内肥素水平的变化
4) visfatin
内脏脂肪素
1.
Effect of exercise on expression of visfatin of visceral fat in high-fat-diet-fed rats;
运动干预对高脂喂养大鼠脂肪组织内脏脂肪素表达的影响
2.
Progress of Visfatin;
内脏脂肪素(visfatin)的研究进展
3.
Expression and significance of visfatin in nonalcoholic fatty liver disease in rat;
内脏脂肪素在大鼠非酒精性脂肪性肝病模型中的变化及作用
5) visfatin
腹脂素
1.
The Expression of ICAM-1 in Endothelium and the Expression of MCP-1 and CD36 in Monocyte/macrophage Induced by Visfatin;
腹脂素对血管内皮细胞ICAM-1和单核细胞MCP-1以及CD36表达的影响
2.
[Objective]To explore relationship between job stress and plasma visfatin.
[目的]探讨职业紧张与血浆腹脂素水平及相关糖脂代谢指标的关系。
6) visfatin
内脏素
1.
Objective To investigate the single nucleotide polymorphism of visfatin promoter-3186 C>T and its relationship with type 2 diabetes.
目的探讨内脏素基因启动子区-3186 C>T的单核甘酸多态性及其与2型糖尿病的相关性。
参考词条
补充资料:降脂奈,降脂素
药物名称:降脂奈
英文名:Nafenopin
别名: 降脂奈,降脂素;纳芬诺平;奈苯丁酸
外文名:Nafenopin
适应症: 作用与用途同氯苯丁酯。
用量用法: 口服:每次100mg,1日3次。
注意事项: 见氯苯丁酯。
规格: 片剂:每片100mg。
类别:调节血脂及抗动脉硬化药
英文名:Nafenopin
别名: 降脂奈,降脂素;纳芬诺平;奈苯丁酸
外文名:Nafenopin
适应症: 作用与用途同氯苯丁酯。
用量用法: 口服:每次100mg,1日3次。
注意事项: 见氯苯丁酯。
规格: 片剂:每片100mg。
类别:调节血脂及抗动脉硬化药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。